#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Metabolic disorder Cold type haemolytic anaemia Thermal burn Hepatoblastoma Allogenic stem cell transplantation Congenital leptin deficiency Pemphigoid Systemic sclerosis pulmonary Diffuse large B-cell lymphoma Chemical burn Conjunctivitis allergic Cervix carcinoma recurrent Hyperadrenocorticism Cutaneous T-cell lymphoma refractory Selective polysaccharide antibody deficiency More trials…

    Learn about Rare Diseases

    Urea cycle disorder – Diagnostics Primary immunodeficiency syndrome Urea cycle disorder – Treatment Encephalitis autoimmune – Diagnostics Shprintzen-Goldberg syndrome – Treatment Angelman’s syndrome – Diagnostics Cholangitis sclerosing – Treatment Antithrombin III deficiency – Diagnostics Waldenstrom’s macroglobulinaemia – Trials in Disease Glomerulonephritis rapidly progressive – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Riluzole Atazanavir Glibenclamide GOCATAMIG Contezolid Amb-05X Metronidazole ZUNIBERGENE ROCPARVOVEC Brexpiprazole Pancreas Powder Nitric Oxide TORASEMIDE Regtivex Abrocitinib Imsidolimab Oxytocin Ht-29-A CIRTUVIVINT Bomedemstat SECRETIN SYNTHETIC HUMAN More therapies…

    Learn about Your Condition

    Behavioural addiction Milk allergy Pancreatic fistula Pancreatitis acute Lichen sclerosus Phaeochromocytoma Uveitis Tardive dyskinesia Aortic valve stenosis Myeloproliferative neoplasm Pancreatitis chronic Neuralgia Sleep disorder Knee arthroplasty Peripheral ischaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiac failure congestive

  • Study on Vitamin D and Oral Iron for Patients with Chronic Heart Failure and Iron Deficiency

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure congestive
    • Cardiac failure chronic
    • Iron deficiency
    Investigated Drugs:
    • Ferric Carboxymaltose
    Italy

  • Study on the Effects of Sacubitril/Valsartan and Ramipril on Heart Function in Patients with Ischemic Heart Failure with Mid-Range Ejection Fraction

    Recruiting

    3 1 1
    Investigated Drugs:
    • Hydrochlorothiazide
    • Ramipril
    • Sacubitril
    Poland

  • Study on Peritoneal Ultrafiltration with PolyCore for Patients with Congestive Heart Failure Using Levocarnitine and Drug Combination

    Recruiting

    4 1 1
    Investigated Diseases:
    • Cardiac failure congestive
    Investigated Drugs:
    • Lactic Acid
    • Levocarnitine
    • Polydextrose
    Italy

  • Study of cardiac atrial stem cells injected into heart muscle for treating advanced heart failure in patients with prior heart attack and reduced heart function

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac failure congestive
    • Chronic left ventricular failure
    • Left ventricular failure
    Belgium

  • Study on the Effects of Dobutamine and Levosimendan in Patients with Heart Failure and Reduced Left Ventricular Function

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure congestive
    • Left ventricular failure
    • Cardiac failure
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • Levosimendan
    Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!